|
⚲
|
| Keyboard |
| Pearson Mark E
✚
|
|
|---|---|
| CIK # | 0001486558 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001486558] | |
| 4 | [0001486558] | |
| 5 | [0001486558] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Galera Therapeutics Inc | |
| Altamont Pharmaceutical Holdings LLC | |
| Pearson Mark E | |
| Soligenix Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-03-28 | Sell | 693,076 | $0.15 | 103,961 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-03-27 | Sell | 306,924 | $0.17 | 52,177 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-03-26 | Sell | 2,000,000 | $0.20 | 400,000 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-03-25 | Sell | 780,000 | $0.22 | 171,600 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-03-22 | Sell | 20,000 | $0.23 | 4,600 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-01-11 | Sell | 400,000 | $0.23 | 92,000 |
|
Soligenix Inc SNGX
Stock Option (Right to Buy) · derivative
|
2019-09-06 | Grant | 30,928 | $0.00 | |
|
Soligenix Inc SNGX
Common Stock
|
2019-06-28 | Grant | 78,338 | $0.71 | 55,620 |
|
Soligenix Inc SNGX
Common Stock
|
2018-10-17 | Buy | 170,000 | $1.16 | 197,200 |
|
Soligenix Inc SNGX
Stock Option (Right to Buy) · derivative
|
2018-09-27 | Grant | 17,964 | $0.00 | |
|
Soligenix Inc SNGX
Stock Option (Right to Buy) · derivative
|
2018-07-20 | Grant | 1,500 | $0.00 |